Estimate fetal fraction of cell-free DNA for NIPT screening. Factor in gestational age, maternal BMI, and twin pregnancy for accurate prediction.
The Fetal Fraction Calculator estimates the percentage of cell-free DNA (cfDNA) in maternal blood that originates from the fetus during pregnancy. Fetal fraction is critical for interpreting Non-Invasive Prenatal Testing (NIPT) results — if the fetal fraction is too low (typically below 4%), the screening cannot reliably detect chromosomal abnormalities like trisomy 21, 18, or 13. It gives a quick planning estimate before the lab report arrives. That helps frame expectations around whether sampling timing may affect test usefulness.
Fetal fraction increases with gestational age and decreases with higher maternal BMI. Twin pregnancies, certain medications, and the testing platform also influence the measured percentage. A low fetal fraction doesn't indicate a problem with the baby but may require retesting at a later gestational age.
Enter your pregnancy parameters to estimate fetal fraction and assess whether it's sufficient for reliable NIPT screening. The calculator shows how your fraction compares to population averages at the same gestational age.
Use this calculator when you want a rough expectation of whether gestational age, BMI, and pregnancy type are likely to produce an adequate fetal fraction before or alongside NIPT. It is mainly useful for planning and context, not for replacing the reported lab value or a clinician’s interpretation. That makes it easier to discuss timing and expectations around screening before the draw or report.
Estimated Fetal Fraction ≈ (0.38 × GA_weeks) + (−0.13 × BMI) + 8.0 (simplified model). Adjusted for twins (+2-3%), gestational diabetes (−1-2%). Minimum for reliable NIPT: 4% (most platforms). Where GA = gestational age in weeks, BMI = body mass index.
Result: 9.4% fetal fraction
At 12 weeks with BMI 24: FF ≈ 0.38×12 + (−0.13×24) + 8.0 = 4.56 − 3.12 + 8.0 = 9.44%. This is well above the 4% minimum threshold. NIPT results should be reliable.
During pregnancy, the placenta sheds DNA fragments into the maternal bloodstream. These cell-free DNA (cfDNA) fragments from the placenta represent the fetal genome and can be analyzed for chromosomal abnormalities without invasive procedures. NIPT has detection rates of 99%+ for trisomy 21 (Down syndrome) and 95-98% for trisomies 18 and 13, with false-positive rates under 0.1%.
The primary factors are gestational age (increases ~0.4% per week from 10-20 weeks), maternal BMI (decreases ~0.13% per BMI point), and the number of fetuses. Other factors include gestational diabetes (slightly lower), certain medications, autoimmune conditions, and the individual variation in placental cfDNA production. Laboratory technique and sequencing depth also influence the measured value.
Low fetal fraction occurs in about 3-5% of NIPT samples. While usually resolved with a repeat draw, persistent low fetal fraction (2+ draws) has been associated in some studies with increased risk of aneuploidy, preeclampsia, and low birth weight. Genetic counseling is recommended when fetal fraction remains insufficient after two attempts.
Most NIPT platforms require a minimum of 4% fetal fraction for reliable results. Some newer platforms can work with as low as 2-3%. Below the threshold, the test should be repeated at a later gestational age or an alternative screening method used.
Higher maternal BMI is associated with increased maternal cfDNA in the blood, which dilutes the fetal component. For every 10-point increase in BMI, fetal fraction decreases by approximately 1.3%. This is the most common reason for low fetal fractions.
NIPT can be performed from 10 weeks onward, but fetal fraction is higher at 12-14 weeks. If you have risk factors for low fetal fraction (high BMI, early gestation), waiting until 12-13 weeks improves the chance of adequate fetal fraction on the first draw.
A low fetal fraction result is reported as "no call" or "insufficient fetal fraction." The patient is usually asked to have a repeat blood draw 1-2 weeks later. Persistent low fetal fraction after two draws may warrant diagnostic testing (amniocentesis or CVS).
Yes. In dizygotic twins, total fetal fraction is higher because two placentas contribute cfDNA. However, the per-fetus fraction may be lower, which can affect detection for individual twins. Monozygotic twins share a placenta and behave similarly to singletons.
Male fetuses tend to have slightly higher fetal fractions than female fetuses, though the difference is small (0.5-1%). This is thought to relate to placental size differences. The difference is clinically insignificant for NIPT reliability.